National Institute Of Cancer Research & Hospital (NICRH)

Haematology department is dealing with haematological malignancies and related disorders in both outdoor and indoor setup. Besides, this department is providing haematology laboratory and day care services also. The department is run by a full set of hematologists that includes two associate professor, two assistant professors, and skilled medical professionals, nurses and supporting staff.

Role of the department:
The aim of this department is to provide hematological services, both clinical and diagnostic service at tertiary level to the patients suffering mainly from hematological malignancy and related disorders, and to help developing human resource in hematology.

Key functions:
a. To provide comprehensive diagnosis and treatment facilities for hematological malignancy patients.
b. To set up of a data bank for cancer registry of haematological malignancy patients with other tertiary cancer care hospital and stakeholders
c. To run post graduate courses and provide training facilities for physicians.
d. Conduct research activities for gathering and sharing knowledge with others.
Scope of work:
1. Bone marrow transplant center establishment is going on. We are committed to start autologous transplant as early as possible.
2. To provide one stop services for diagnosis and evaluation of malignancies and patients management. 3. To provide specialized training facilities, workshop, hands on training for haematologists and nurses . 4. Rehabilitation of cancer survivors.
5. Create public awareness for prevention and control of cancer.

History and establishment:
a. Haematology department starts its activities since 2004. At that time, all the patients care had given under supervision of oncology unit. Since 2006, the department had run by its own by Professor Md. Mahbubur Rahman. He started outdoor patient service and developed day care service and laboratory services with a very few measures like set up of a cell counter machine and blood film examination by microscope. Gradually indoor admission facilities started.

b. Milestone and major achievements:
2004: The Department of Haematology was established at NICRH in 2004 that started its synchronized activities of indoor, outdoor, day care center and laboratory works in 2006.
2012: Coagulation profile tests started on 2012.
2016: Automated cell counter (Sysmax 5 part machine ) set up on 2016.
2019: Automated Coagulation profile tests started on 2019
2022: All tests for multiple myeloma profile has started on 2022.
2023: Flowcytometry started its journey to confirm molecular diagnosis for haematological malignancies.

1. Outpatient Department

Description: Located on the 6th floor, D block. All patients require an outdoor ticket with online registration and should report to Room No. 720. Registries are completed at Room No. 720, after which a tag number is provided to attend physicians in various rooms.

Availability: 8:30 AM to 1:00 PM

Appointment Required: Yes (online registration and tag number system)

2. Laboratory Services

Description: Laboratory is on the 8th floor and is a restricted area. Sample collection is in Room No. 720, and bone marrow collection is in Room No. 701. Blood samples are collected at the same place, and bone marrow aspiration is performed in Room No. 701.

Availability: 8:30 AM to 1:00 PM

Appointment Required: No (samples collected directly within the specified times)

3. Day Care Service

Description: Registered hemato-oncology cancer patients register for day care service. After obtaining written consent from physicians, they receive chemotherapy from the day care center. Physicians provide written permission for chemotherapy.

Availability: 8:30 AM to 2:00 PM

Appointment Required: Yes (written consent from physicians is required)

4. Indoor Service

Description: We have 42 beds for indoor admission services (27 for male patients, 15 for female patients). Admission to cabins is decided by the administrative block of NICRH. Indoor admission is located in the hospital building.

Availability: 24 hours service

Appointment Required: Yes (assigned hematologists decide who will be admitted)

5. Specialized Facilities & Technologies

a. Diagnostic tools:

1. Flow-cytometry for immunophenotyping (acute leukaemia panel)

2. Serum protein immunoelectrophoresis

3. Urine immunoelectrophoresis

4. Free light chain assay

b. Autologous bone marrow stem cell transplantation will be started within a short period of time.

Vision
Our vision is to provide exemplary patient care, applying advanced scientific knowledge through cutting-edge technologies like flow cytometry, and offer life-saving therapies such as bone marrow transplantation—ultimately striving to improve outcomes and quality of life for all patients affected by haematological conditions.
Mission
The Haematology Department is dedicated to delivering comprehensive, evidence-based care for patients with malignant and non-malignant blood disorders. Our mission is grounded in the following core commitments:
Excellence in Patient Care: To provide compassionate, personalized, and state-of-the-art diagnostic and therapeutic services to every patient.
Innovation and Research: To advance the field of haematology through ongoing research, clinical trials, and the integration of new technologies.
Education and Training: To foster the next generation of clinicians, scientists, and healthcare professionals through structured training and mentorship.
Collaboration and Multidisciplinary Approach: To work in synergy with other specialties, laboratories, and research institutions for holistic patient management.
Community Outreach and Awareness: To promote early diagnosis, prevention, and education regarding haematological diseases within the community.
Ethics and Integrity: To uphold the highest standards of professionalism, accountability, and ethical practice in all aspects of our work.

Research & Academic Activities
A. Ongoing Research Project
Title: Unveiling the Role of Biomarkers Polymorphism in the Response and Toxicities of Cytarabine and Daunorubicin in Acute Myeloid Leukemia among the Bangladeshi Population
Researcher: Mohammad Sarowar Uddin
Position: Assistant Professor & PhD Student
Institution: Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali
B. Academic Program
Weekly CME: Conducted every Wednesday by the Department of Hematology.
Central CME Participation: Active participation in weekly Central CME, grand rounds, and death reviews organized by NICRH according to the central roster.

C. Publications
Comorbidity and Its Impact on Patients with COVID-19
Salina Haque, Mohammad Ali, Tamannah Bahar, Muhammad Nazrul Islam, Mohammad Wasim, Md. Ashraful Haque Chowdhury, Keya Tarafder, Goutam Kumar Acherjya
SAS Journal of Medicine, March 6, 2025, Vol. 11(3): 144–149
DOI: https://doi.org/10.36347/sasjm.2025.v11i03.003
Outcome of Relapsed or Refractory Diffuse Large B-cell Lymphoma with Second-line Chemotherapy Ifosfamide-Carboplatin-Etoposide with or without Rituximab
S. Haque, Z. Z. Chowdhury, T. Bahar, S. T. Reshma, A. K. M. Islam, M. Ali, M. M. Rahman
Mymensingh Med J., Oct 2024; 33(4):1176–1183
PMID: 39351741
Clinical Consequences and Economic Burden Associated with Febrile Neutropenia in Hospitalized Cancer Patients: A Prospective Study
Tamanna Bahar, Shaila Rahman, Zulfia Zinat Chowdhury, Tania Kabir, Fahmida Akther, Salina Haque, AKM Mynul Islam, Mohammad Ali, Md. Mahbubur Rahman
J Medicine, 2022; 23:48–53
DOI: https://doi.org/10.3329/jom.v23i1.57937
Symptomatic Outcome of CTDa in Multiple Myeloma Patients
Zulfia Zinat Chowdhury, Mohammad Ali, AKM Mynul Islam, Salina Haque, Tammana Bahar, Amin Lutful Kabir
KYAMC Journal, Oct 2020; 11(3):124–128
Safety and Efficacy of Biosimilar Rituximab in Management of Lymphoproliferative Diseases
Islam AKMM, Ali M, Haque S, Chowdhury ZZ, Rahman MM
Bangladesh Oncology Journal, 2016; 11(1&2):45–50
Official Journal of Bangladesh Society of Radiation Oncologists
Immunophenotypic Characterisation Along with Aberrant Expression of CD Markers in Morphologically Diagnosed Cases of Acute Myeloid Leukemia
Salina Haque, Zulfia Zinat Chowdhury, Tamanna Bahar, Samira Taufique Reshma, AKM Mynul Islam, Mohammad Ali, Jannatul Ferdouse, Md. Mahbubur Rahman
J Medicine, 2022; 23:106–111
DOI: https://doi.org/10.3329/jom.v23i2.60626

D. Training and Education
Fellowship Programs: No
Residency: Not started yet
Workshops:
Flow Cytometry Workshop at NICRH – November 6, 2023
Online Flow Cytometry Workshops by Thermo Fisher Officials – Several sessions
CME:
May 28, 2025 – Celebration of World Blood Cancer Day and Scientific Session organized by the Department of Hematology, NICRH, and the Haematology Society of Bangladesh.

  • Department Name: Hematology Department
     • Head of Department (HOD): Dr. A. K. M Mynul Islam
     • Designation: Associate Professor
     • Contact Email & Phone: 01720054636, drmynulislam75@gmail.com
      • Office Location : Block D, information center at 6th floor and room no 701 and 720
     • Working Hours: 8 am to 2:30 pm

গণপ্রজাতন্ত্রী বাংলাদেশ সরকার

জাতীয় ক্যান্সার গবেষণা ইনস্টিটিউট ও হাসপাতাল